IMMUNOMEDICS INC 3 SEC Filings

Filed On	Filing
20 Apr 2020	Form 3: Semerjian Harout, Director No securities owned
27 Feb 2020	Form 3: Azelby Robert, Director No securities owned
18 Feb 2020	Form 3: Itri Lorettta M, Chief Medical Officer Holds 15,000 shares of Common Stock, par value $0.01 per share
07 Mar 2019	Form 3: Duncan Barbara Gayle, Director No securities owned
07 Mar 2019	Form 3: Ball Bryan, Chief Quality Officer No securities owned
26 Feb 2019	Form 3: Baum Charles M, Director No securities owned
27 Sep 2018	Form 3: Andrews Kurt J., CHIEF HUMAN RESOURCES OFFICER
26 Sep 2018	Form 3: Freedberg Jared, GENERAL COUNSEL No securities owned
07 Sep 2018	Form 3: Fricker William, See Remarks
15 May 2018	Form 3: Rosenberg Morris, See Remarks
23 Apr 2018	Form 3: Malik Usama, See Remarks Holds 5,000 shares of Common stock, par value $0.01 per share
23 Apr 2018	Form 3: Iannone Robert, See Remarks
11 Dec 2017	Form 3: Pehl Michael F., President and CEO No securities owned
14 Nov 2017	Form 3: Delaney Brendan, Chief Commercial Officer No securities owned
23 Mar 2017	Form 3: Aghazadeh Behzad, Director and 1 other Holds 10,488,076 shares of Common Stock, $0.01 par value per share (the "Common Stock")
23 Mar 2017	Form 3: Canute Scott A, Director No securities owned
23 Mar 2017	Form 3: Hutt Peter Barton, Director No securities owned
23 Mar 2017	Form 3: Islam Khalid, Director No securities owned
12 Jan 2017	Form 3: Oliver Bob, Director No securities owned
10 Jan 2017	Form 3: Cox Geoffrey F, Director No securities owned

Comments